Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Krogh

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Ugeskrift for Laeger|January 23, 2026
[Clozapine for elderly people with schizophrenia]Philip Lindblad Thorsen, Jesper Krogh Lauridsen, Samuel Azuz
The Journal of Clinical Psychiatry|July 4, 2009
The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depressionJesper Krogh, Bengt Saltin, Christian Gluud, et al.
Endocrine Connections|September 14, 2019
Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysisSarah Byberg, Jesper Futtrup, Mikkel Andreassen, et al.
Journal of Affective Disorders|February 13, 2010
Growth hormone, prolactin and cortisol response to exercise in patients with depressionJesper Krogh, Merete Nordentoft, Mahdi Mohammad-Nezhad, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitusBianca Hemmingsen, Jesper Krogh, Maria-Inti Metzendorf, et al.
Current Neuropharmacology|September 20, 2016
Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentOle Kohler, Jesper Krogh, Ole Mors, et al.
Clinical Endocrinology|September 30, 2020
Metabolic and hormonal side effects of mitotane treatment for adrenocortical carcinoma: A retrospective study in 50 Danish patientsMalene Elbaek Vikner, Jesper Krogh, Gedske Daugaard, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2023
Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes InsipidusAslak Nykjær Pedersen, Mikkel Andreassen, Aase Krogh Rasmussen, et al.
Contemporary Clinical Trials|August 29, 2006
Design paper: the DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of aerobic versus non-aerobic versus relaxation training for patients with light to moderate depressionJesper Krogh, Lone Petersen, Michael Timmermann, et al.
BMJ (Clinical Research Ed.)|August 24, 2012
Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trialBritt Morthorst, Jesper Krogh, Annette Erlangsen, et al.
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Ugeskrift for Laeger|January 23, 2026
[Clozapine for elderly people with schizophrenia]Philip Lindblad Thorsen, Jesper Krogh Lauridsen, Samuel Azuz
The Journal of Clinical Psychiatry|July 4, 2009
The DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of strength versus aerobic versus relaxation training for patients with mild to moderate depressionJesper Krogh, Bengt Saltin, Christian Gluud, et al.
Endocrine Connections|September 14, 2019
Metabolic effects of dopamine agonists in patients with prolactinomas: a systematic review and meta-analysisSarah Byberg, Jesper Futtrup, Mikkel Andreassen, et al.
Journal of Affective Disorders|February 13, 2010
Growth hormone, prolactin and cortisol response to exercise in patients with depressionJesper Krogh, Merete Nordentoft, Mahdi Mohammad-Nezhad, et al.
The Cochrane Database of Systematic Reviews|April 22, 2016
Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitusBianca Hemmingsen, Jesper Krogh, Maria-Inti Metzendorf, et al.
Current Neuropharmacology|September 20, 2016
Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentOle Kohler, Jesper Krogh, Ole Mors, et al.
Clinical Endocrinology|September 30, 2020
Metabolic and hormonal side effects of mitotane treatment for adrenocortical carcinoma: A retrospective study in 50 Danish patientsMalene Elbaek Vikner, Jesper Krogh, Gedske Daugaard, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|October 25, 2023
Desmopressin Dose Requirements in Adults with Congenital and Acquired Central Diabetes InsipidusAslak Nykjær Pedersen, Mikkel Andreassen, Aase Krogh Rasmussen, et al.
Contemporary Clinical Trials|August 29, 2006
Design paper: the DEMO trial: a randomized, parallel-group, observer-blinded clinical trial of aerobic versus non-aerobic versus relaxation training for patients with light to moderate depressionJesper Krogh, Lone Petersen, Michael Timmermann, et al.
BMJ (Clinical Research Ed.)|August 24, 2012
Effect of assertive outreach after suicide attempt in the AID (assertive intervention for deliberate self harm) trial: randomised controlled trialBritt Morthorst, Jesper Krogh, Annette Erlangsen, et al.
Pageof 10